Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O
Second Department of Internal Medicine, Sapporo Medical College, Japan.
Cardiovasc Res. 1992 May;26(5):456-61. doi: 10.1093/cvr/26.5.456.
The aims were to examine the role of adenosine receptors in the mechanism of preconditioning in a chronic rabbit model of myocardial infarction; to assess whether the preconditioning effect is blocked by an adenosine receptor antagonist, 8-phenyltheophylline; and to determine whether an adenosine A1 receptor agonist, R(-)N6-2-phenylisopropyl adenosine (R-PIA), mimics infarct size limitation by preconditioning.
Myocardial infarction was induced in male rabbits by occlusion of the left coronary artery for 30 min, which was followed by 72 h reperfusion. Before the 30 min ischaemia, rabbits were subjected to one of the following six protocols: (1) untreated control; (2) intravenous injection of 8-phenyltheophylline; (3) preconditioning with 5 min ischaemia; (4) pretreatment with 8-phenyltheophylline plus preconditioning; (5) intravenous injection of R-PIA; or (6) R-PIA plus atrial pacing (240.min-1). Infarct size and area at risk were determined by histology and fluorescent particles, respectively.
Preconditioning significantly limited infarct size, normalised as a percent of area at risk (%IS/AR), to 19.2 (SEM 2.3)% v control value of 46.5(2.8)%. 8-Phenyltheophylline alone did not modify the %IS/AR, but its injection before preconditioning attenuated the preconditioning effect such that IS/AR = 34.4(2.5)%. While R-PIA did not achieve statistically significant myocardial salvage, R-PIA plus atrial pacing limited infarct size to 33.7(3.0)% (p<0.05 v control). The R-PIA group had severe hypotension and their infarct sizes were inversely correlated with diastolic blood pressure at reperfusion. There was no such correlation in the R-PIA plus pacing group in which bradycardia and hypotension induced by R-PIA were attenuated by atrial pacing.
The infarct size limiting effect of preconditioning was attenuated by 8-phenyltheophylline, and pretreatment with R-PIA was able to limit myocardial infarct size when severe hypotension was avoided by atrial pacing. These findings suggest that adenosine receptor activation plays a crucial role in the mechanism of preconditioning.
本研究旨在探讨腺苷受体在慢性兔心肌梗死预处理机制中的作用;评估腺苷受体拮抗剂8-苯基茶碱是否会阻断预处理效应;并确定腺苷A1受体激动剂R(-)N6-2-苯基异丙基腺苷(R-PIA)是否能模拟预处理对梗死面积的限制作用。
通过结扎雄性兔左冠状动脉30分钟诱导心肌梗死,随后进行72小时再灌注。在30分钟缺血前,将兔分为以下六种方案之一:(1)未处理的对照组;(2)静脉注射8-苯基茶碱;(3)5分钟缺血预处理;(4)8-苯基茶碱预处理加预处理;(5)静脉注射R-PIA;或(6)R-PIA加心房起搏(240次/分钟)。分别通过组织学和荧光颗粒测定梗死面积和危险面积。
预处理显著限制了梗死面积,以危险面积的百分比(%IS/AR)表示,从对照组的46.5(2.8)%降至19.2(2.3)%。单独使用8-苯基茶碱未改变%IS/AR,但在预处理前注射可减弱预处理效果,使IS/AR = 34.4(2.5)%。虽然R-PIA未达到统计学上显著的心肌挽救效果,但R-PIA加心房起搏将梗死面积限制在33.7(3.0)%(与对照组相比,p<0.05)。R-PIA组出现严重低血压,其梗死面积与再灌注时的舒张压呈负相关。在R-PIA加起搏组中没有这种相关性,其中R-PIA引起的心动过缓和低血压通过心房起搏得到缓解。
8-苯基茶碱减弱了预处理对梗死面积的限制作用,当通过心房起搏避免严重低血压时,R-PIA预处理能够限制心肌梗死面积。这些发现表明腺苷受体激活在预处理机制中起关键作用。